1. Nicolle LE. Epidemiology of urinary tract infections. Infect Med . 2001;18:153-162.
2. Centers for Disease Control and Prevention. Annual number and percent distribution of ambulatory care visits by setting type according to diagnosis group: United States, 2009-2010. Available at: www.cdc.gov/nchs/data/ahcd/combined_tables/2009-2010_combined_web_table01.pdf . Accessed August 31, 2016.
3. Griebling TL. Urologic diseases in America project: trends in resource use for urinary tract infections in women. J Urol . 2005;173:1281-1287.
4. Ikaheimo R, Siitonen A, Heiskanen T, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis . 1996;222:91-99.
5. Sammon JD, Sharma P, Rahbar H, et al. Predictors of admission in patients presenting to the emergency department with urinary tract infection. World J Urol . 2014;32:813-819.
6. Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis . 2005;40:643-654.
7. Barber AE, Norton JP, Spivak AM, et al. Urinary tract infections: current and emerging management strategies. Clin Infect Dis . 2013;57:719-724.
8. Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med . 2012;366:1028-1037.
9. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 91: treatment of urinary tract infections in nonpregnant women. Obstet Gynecol . 2008;111:785-794.
10. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, et al. Association of the Lewis blood group phenotype with recurrent urinary tract infections in women. N Engl J Med . 1989;320:773-777.
11. Foxman B, Gillespie B, Koopman J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol . 2000;151:1194-1205.
12. Twaij M. Urinary tract infection in children: a review of its pathogenesis and risk factors. J R Soc Health . 2000;120:220-226.
13. Scholes D, Hooton TM, Roberts DL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis . 2000;182:1177-1182.
14. Hooton TM, Fennell CL, Clark AM, et al. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. J Infect Dis. 1991;164:1216-1219.
15. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. New Eng J Med . 1996;335:468-474.
16. Hooton TM, Hillier S, Johnson C, et al. Escherichia coli bacteriuria and contraceptive method. JAMA . 1991;265:64-69.
17. Foxman B, Marsh J, Gillespie B, et al. Condom use and first-time urinary tract infection. Epidemiology . 1997;8:637-641.
18. Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J . 2011;5:316-322.
19. Hooton TM. Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother . 2000;46(Suppl 1):1-7.
20. Raz R, Gennesin Y, Wasser J, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30:152-156.
21. Gupta K, Stapleton AE, Hooton TM, et al. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli in women with recurrent urinary tract infections. J Infect Dis . 1998;178:446-450.
22. Neal DE. Complicated urinary tract infections. Urol Clin North Am . 2008;35:13-22.
23. Amna MA, Chazan B, Raz R, et al. Risk factors for non-Escherichia coli community-acquired bacteriuria. Infection . 2013;41:473-477.
24. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis . 2011;52:e103-e120.
25. U.S. Food and Drug Administration. FDA drug safety communication. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM500591.pdf . Accessed November 7, 2016.
26. Katchman EA, Milo G, Paul M, et al. Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis. Am J Med . 2005;118:1196-1207.
27. Milo G, Katchman EA, Paul M, et al. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database Syst Rev . 2005;(2):CD004682.
28. Gupta K, Hooton TM, Roberts PL, et al. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med . 2001;135:9-16.
29. Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am . 1987;1:793-806.
30. Ronald AR, Conway B. An approach to urinary tract infections in ambulatory women. Curr Clin Top Infect Dis . 1988;9:76-125.
31. Aydin A, Ahmed K, Zaman I, et al. Recurrent urinary tract infections in women. Int Urogynecol J . 2015;26:795-804.
32. McLaughlin SP, Carson CC. Urinary tract infections in women. Med Clin North Am . 2004;88:417-429.
33. Albert X, Huertas I, Pereiro II, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev . 2004;(3):CD001209.
34. Melekos MD, Asbach HW, Gerharz E, et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol . 1997;157:935-939.
35. Chew LD, Fihn SD. Recurrent cystitis in nonpregnant women. West J Med . 1999;170:274-277.
36. Stapleton A, Latham RH, Johnson C, et al. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection: A randomized, double-blind, placebo-controlled trail. JAMA . 1990;264:703-706.
37. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev . 2012;(10):CD001321.
38. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis . 2011;52:1212-1217.
39. Beerepoot MA, ter Riet G, Nys S, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med . 2012;172:704-712.
40. Perrotta C, Aznar M, Mejia R, et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev . 2008;(2):CD005131.
41. Foxman B, Chi JW. Health behavior and urinary tract infection in college-aged women. J Clin Epidemiol . 1990;43:329-337.
42. Lee BB, Simpson JM, Craig JC, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev . 2007;(4):CD003265.
43. Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol . 2014;32:79-84.